MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/jsap.13874

Медицинская библиотека · The Journal of small animal practice · 2025

Evaluation of lung lobectomy and adjuvant treatment for primary pulmonary carcinoma in dogs: 89 cases (2005-2022).

Treggiari E, Romanelli G, Valenti P, Montinaro V, Rossanese M

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVES

Primary lung cancer is relatively common in dogs. Despite the existing literature on long-term follow-up and outcome, further clinical studies focusing on a single histotype are needed, specifically about epithelial tumours since they are the ones most frequently detected.

MATERIALS AND

METHODS

The medical records of four European institutions were reviewed to identify dogs undergoing lung lobectomy for a primary lung carcinoma between 2005 and 2022.

RESULTS

A total of 89 dogs were included. Median age was 11 years (range 5 to 17 years) and median body weight was 23 kg (range 2.5 to 47 kg). Overall median survival time was 252 days (range 6 to 1558 days) and overall progression-free interval was 140 days (range 7 to 684 days). The 1-, 2- and 3-year survival rates were 61%, 47% and 30%, respectively. Presence of clinical signs at presentation, pleural effusion, completeness of surgical margins, histopathological features and use of adjuvant chemotherapy did not influence survival. Patients with maximum tumour diameter ≥ 5 cm had a reduced survival compared to patients with smaller tumours (median survival time 284 days vs. 717 days, 95% CI 8 to 719), and dogs with histologically confirmed lymph node metastasis had a reduced survival compared to patients with no evidence of local metastasis (median survival time 162 days vs. 614 days, 95% CI 39 to 760). None of the other assessed variables influenced progression-free interval.

CLINICAL SIGNIFICANCE: Dogs with primary pulmonary carcinoma with no lymph node involvement and with a maximum tumour diameter of < 5 cm may have a better prognosis and prolonged survival. Further studies are needed to elucidate the role of adjuvant chemotherapy in case of clinically aggressive lung cancer.

Для цитирования: Treggiari E, Romanelli G, Valenti P, Montinaro V, Rossanese M. Evaluation of lung lobectomy and adjuvant treatment for primary pulmonary carcinoma in dogs: 89 cases (2005-2022).. The Journal of small animal practice. 2025. DOI: 10.1111/jsap.13874.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.